Events | 2018.03.08
Visikol Launches Improved Visikol® HISTO-M™ Reagent for the Visualization of 3D Cell Culture Models
As a drug discovery contract research organization, Visikol is committed to providing enhanced in vitro assays that reduce the translational gap between in vitro and in vivo studies. Visikol HISTO-M now allows for advanced 3D cell culture models to be characterized in their entirety and for complex biological questions to be answered in a high-throughput in vitro format.
(PRWeb March 08, 2018)
Read the full story at http://www.prweb.com/releases/2018/03/prweb15264931.htm
For more information, please visit
http://www.prweb.com/releases/2018/03/prweb15264931.htm
